CAS: 78649-41-9; N1,N3-Bis(2,3-Dihydroxypropyl)-5-(2-Hydroxy-N-Methylacetamido)-2,4,6-Triiodoisophthalamide

该化合物是一种主要用于医疗成像的非离子碘化对比剂,特别是在计算断层扫描和血管成像中,其特征是低悬浮度,与旧对比剂相比,它最大限度地减少了不良反应的风险.Iomeprol是水溶性,可以容易地通过肾脏进行管理和快速排泄.它的化学结构包括碘,它能提高放射性度,使其在成像过程中能够有效地直观地显示血管结构和器官.该物质一般都得到良好的调试,与离子对比剂相比,过敏反应和...

结构式图片

MSDS等安全信息

    上下游产品

    5-aminoisophthalic acid 5-methylaminoisophthalic acid dimethyl ester 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide 5-amino-N,N'-bis[2,3-bis(acetyloxy)propyl]2,4,6-triiodo-1,3-benzenedicarboxamide

    合成工艺路线路线简述

    • 合成目标产物 Iomeprol 主要起始原料 N-Desmethyl Iomeprol And Iodomethane
    • (文献来源)合成步骤主要原料 N-Desmethyl Iomeprol 和 Iodomethane
    5-[[2-(乙酰氧基)乙酰基]氨基]-2,4,6-三碘-1,3-苯二甲酰氯置于水,三乙胺,Sodium Hydroxide体系中,用 N,N-二甲基乙酰胺 作为反应溶剂,化学反应 23.0H,反应生成 碘美普尔
    参考文献:조영제 중간체의 신규 제조방법 및 이를 이용한 조영제의 제조방법
    标题:조영제 중간체의 신규 제조방법 및 이를 이용한 조영제의 제조방법
    摘要:本发明的制造方法通过简化造影剂的中间体或造影剂制造过程,减少废溶剂的反应生成,环保性强,并且可以显著降低制造成本.因此,本发明的制造方法可以大幅降低造影剂的生产成本,经济实惠,适合大规模生产.

    海关参考信息

    专利信息


    专利号:US-9157156-B2
    优先权日:2009-07-07
    标题 :Process for the preparation of a iodinating agent
    发明人:ANELLI PIER LUCIO; VISCARDI CARLO FELICE; DELOGU PIETRO; GOFFREDI FABRIZIO; NARDELLI ALFONSO; GIOVENZANA GIOVANNI BATTISTA
    权利人:ANELLI PIER LUCIO; VISCARDI CARLO FELICE; DELOGU PIETRO; GOFFREDI FABRIZIO; NARDELLI ALFONSO; GIOVENZANA GIOVANNI BATTISTA; BRACCO IMAGING SPA
    摘要:The present invention describes a process for the synthesis of a iodinating agent, being said iodinating agent iodine chloride (ICI.) In particular, the present invention relates to a process for the electrochemical preparation of ICI, as a useful iodinating agent in the preparation of iodinated organic compounds for use as contrast agents or their precursors in the synthesis of the same.

    专利号:US-2022233673-A1
    优先权日:2019-06-04
    标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
    发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
    权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
    摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

    专利号:US-10836711-B2
    优先权日:2017-02-10
    标 题 :Method for the one-pot production of organo-iodinated compounds
    发明人:PETTA MYRIAM; PELLINGHELLI STEPHAN
    权利人:GUERBET SA
    摘要:The present invention concerns a process for the preparation of organo-iodized compounds, as well as their preparation intermediates. More particularly, the present invention concerns a process for the preparation of organo-iodized compounds which can be used as preparation intermediates in the synthesis of iodized contrast agents.

    专利号:US-12269790-B1
    优先权日:2022-04-29
    标题:Process for the preparation of 2,4,6-triiodophenol derivatives
    发明人:BARANYAI ZSOLT; GUIDOLIN NICOL; LAZZARI FEDERICA; UGGERI FULVIO
    权利人:BRACCO IMAGING SPA
    摘要:The invention relates to a process for the preparation of a 2,4,6-triiodo-phenol derivative of formula (II), which is useful as an intermediate for the synthesis of conventional X-ray contrast agents, said process comprising the tri-iodination of the correspondent phenol derivative of said 2,4,6-triiodo-phenol derivative by means of an iodinating system comprising I 2 and an oxide or a salt of an element of group 11 of the periodic table.

    专利号:US-10836710-B2
    优先权日:2016-12-05
    标 题 :Mechanochemical synthesis of radiographic agents intermediates
    发明人:BARGE ALESSANDRO; BARICCO FRANCESCA; CRAVOTTO GIANCARLO; FRETTA ROBERTA; LATTUADA LUCIANO
    权利人:BRACCO IMAGING SPA
    摘要:The present invention generally relates to a process using a mechanochemical approach exploiting the mechanical milling of reactants for the manufacturing of acetyl Iopamidol and, more generally, of key intermediates of radiographic contrast agents, and of the contrast agents themselves.

    专利号:US-9382194-B2
    优先权日:2011-10-31
    标 题:Iodination process for the preparation of 3, 5-disubstituted-2, 4, 6-triiodo aromatic amines compounds
    发明人:XING HONGDENG; LI LEI; HU ZHIQI
    权利人:XING HONGDENG; LI LEI; HU ZHIQI; IMAX DIAGNOSTIC IMAGING HOLDING LTD
    摘要:The invention discloses a improved process for the preparation of 3,5-disubstituted-2,4,6-triiodo aromatic amines of formula (II), wherein R 1 and R 2 are defined as herein. The compounds of formula (II) are the key intermediates for the synthesis of a series of non-ionic contrast agents such as Iopamidol, Iohexol and Iodixanol. The process comprises reacting chlorine-free iodinating reagents with 3,5-disubstituted-2,4,6-triiodo aromatic amines to obtain 3,5-disubstituted-2,4,6-triiodo aromatic amines of formula (II), wherein the molar yield of the iodination reaction can reach to 89%.
    江苏宇田医药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jsytsw.com
    企业联系电话:0518-86098000;86098017👤
    📞江苏宇田医药股份有限公司 ⚠️参考联系方式
    联系人:王先生;樊女士
    电话:0518-86098000;86098017
    手机:15261372765;18861350683

    邮箱:sales@jsytsw.com
    通信地址: 江苏连云港市经济技术开发区大浦工业区临浦路22号
    邮编: 222000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏连云港市经济技术开发区大浦工业区临浦路22号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北天舒药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tianshupharm.com
    企业联系电话:0710-4280293;18771522777刘经理👤
    📞湖北天舒药业有限公司 ⚠️参考联系方式
    联系人:刘经理
    电话:0710-4280293;18771522777刘经理
    手机:18771522777刘经理
    传真:0710-4280291
    邮箱:1192828343@qq.com
    通信地址: 宜城市精细化工产业园雷河南路
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:宜城市精细化工产业园雷河南路
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北志化医药化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zhihuachem.com
    企业联系电话:13797666691👤
    📞湖北志化医药化学有限公司 ⚠️参考联系方式
    联系人:杨经理
    电话:13797666691
    手机:13797666691
    传真:0710-4280293
    邮箱:zhsale@zhihuachem.com
    通信地址: 湖北宜城市流水镇原邓林农场三分场境内
    邮编: 441419
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北宜城市流水镇原邓林农场三分场境内
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Nierengarten MB. Imlunestrant significantly improves PFS for patients with advanced breast cancer. Cancer. 2025 Jul 1;131(13):e35913. doi: 10.1002/cncr.35913. 14(10):764-775. doi: 10.1002/cpdd.1562. Epub 2025 Jun 24.
    3: Sherman S, Sandusky ZM, Russo D, Zak D, Nardone A, Friel D, Hermida-Prado F, Heraud C, Kuziel G, Verma A, Gaglia G, Kabraji S, Nguyen QD, Santagata S, Fanning SW, Jeselsohn R. Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor-positive breast cancer. JCI Insight. 2025 May 6;10(12):e188051. doi: 10.1172/jci.insight.188051.
    4: Alva-Bianchi M, Sánchez-Bayona R, Ciruelos E. Oral SERDs: Transforming the treatment of advanced breast cancer-Insights from EMBER-3. Med. 2025 Feb 14;6(2):100602. doi: 10.1016/j.medj.2025.100602. 76(1):243-255. doi: 10.1146/annurev-med-052423-122001. 22(3):157. doi: 10.1038/s41571-024-00983-y. EMBER-3 Study Group. Imlunestrant with or without Abemaciclib in Advanced Breast Cancer. N Engl J Med. 2025 Mar 27;392(12):1189-1202. doi: 10.1056/NEJMoa2410858. Epub 2024 Dec 11. 85(4):777-790. doi: 10.1158/0008-5472.CAN-24-2608.

    合成参考文献


    参考文献:10.1007/s00330-010-1725-7
    摘要:Schepis T, Achenbach S, Marwan M, Muschiol G, Ropers D, Daniel WG, Pflederer T. Prevalence of first-pass myocardial perfusion defects detected by contrast-enhanced dual-source CT in patients with non-ST segment elevation acute coronary syndromes. Eur Radiol. 2010 Jul;20(7):1607–14. doi: 10.1007/s00330-010-1725-7.
    参考文献:10.1007/s00270-011-0222-y
    摘要:Kamper L, Meyn H, Rybacki K, Nordmeyer S, Kempkes U, Piroth W, Isenmann S, Haage P. Workflow Optimization in Vertebrobasilar Occlusion. CardioVascular and Interventional Radiology. 2011 Jul 06;35(3):491–7. doi: 10.1007/s00270-011-0222-y.
    参考文献:10.1097/rct.0b013e31821f4e00
    摘要:Tatsugami F, Matsuki M, Nakai G, Inada Y, Kanazawa S, Takeda Y, Morita H, Takada H, Yoshikawa S, Fukumura K, Narumi Y. Body Size-Adapted Dose of Contrast Material and Scanning Protocol in 320-Detector Row CT Coronary Angiography. Journal of Computer Assisted Tomography. 2011 Jul;35(4):475–9. doi: 10.1097/rct.0b013e31821f4e00.
    参考文献:10.1007/s00330-011-2200-9
    摘要:Bellin M, Stacul F, Webb JAW, Thomsen HS, Morcos SK, Almén T, Aspelin P, Clement O, Heinz-Peer G, Reimer P, van der Molen A, on behalf of the Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Late adverse reactions to intravascular iodine based contrast media: an update. European Radiology. 2011 Jul 16;21(11):2305. doi: 10.1007/s00330-011-2200-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知